Home »
In the gyms and while Running many people listen to music. The benefits have been proven by many studies, for example, the music distracts from listening to exertion, and boredom. Particularly in endurance sports, the
A single dose of a highly diluted VSV-Ebola virus (EBOV) vaccine—approximately one-millionth of what is in the vaccine being used to help control the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC)—remains
Scientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice. The drug quinacrine was used extensively to prevent and treat malaria in soldiers fighting
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne
It’s official. We all hate cardio. It makes our lungs hurt, it makes us excessively sweaty, it makes us want to cry. Particularly running. Unfortunately, cardio is a really crucial part of your fitness regime
A new study has shown how cannabis could be an effective treatment option for both pain relief and insomnia, for those looking to avoid prescription and over the counter pain and sleep medications—including opioids. The
Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs), according to research presented at the Society of Nuclear Medicine and Molecular Imaging’s
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical
Patients with schizophrenia are often treated with more than one type of psychiatric medication, but a new study suggests that some combinations may be more effective than others. The findings were published in JAMA Psychiatry.
WEDNESDAY, Feb. 13, 2019 — Neoadjuvant administration of programmed cell death protein 1 (PD-1) blockade seems to enhance local and systemic antitumor immune response in glioblastoma, according to a study published online Feb. 11 in